Proceeding of the 32nd Annual General Meeting of the Company under Regulation 30 of SEBI(Listing obligations and disclosure Requirements) Regulations 2015.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kimia Biosciences held its 32nd AGM on Tuesday, September 30, 2025 at 4:00 PM IST via video conferencing, chaired by CEO and Managing Director Mr. Sameer Goel. The Company Secretary, Ms. Pallavi Garg, confirmed the presence of the required quorum, and the meeting lasted about 13 minutes, concluding at 4:13 PM. Five ordinary resolutions were taken up, covering adoption of the audited financial statements for FY ended 31st March 2025, re-appointment of Mr. Sameer Goel as a director (who retires by rotation), appointment of M/s Neeraj Arora & Associates as statutory auditors until the 37th AGM, approval of cost auditors' remuneration for FY ending 31st March 2026, and appointment of Mr. Harish Kumar as secretarial auditor for five financial years (FY2025-26 to FY2029-30). Voting was conducted electronically through NSDL's remote e-voting platform, with no shareholder questions raised beyond one speaker, Mr. Pramod Jain, who appreciated the company's performance.
This was a routine procedural AGM with no major corporate actions, dividend declarations, fund raises, or strategic announcements, so it is unlikely to materially affect the stock price or shareholder value in the short term.